Who owns AMBRX BIOPHARMA INC?
- CUSIP Number: 02290a102
Tip: Access positions for across all investors
Analyze quarterly positions in Ambrx Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ambrx Biopharma stock
Who bought or sold AMBRX BIOPHARMA INC this quarter?
There are no current stakeholders of Ambrx Biopharma.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Ambrx Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Federated Investors | Sep 2023 | 2.4M | $28M |
| FMR | Sep 2023 | 1.8M | $20M |
| ExodusPoint Capital Management | Sep 2023 | 493k | $5.7M |
| HighVista Strategies | Sep 2023 | 194k | $2.2M |
| Susquehanna International | Sep 2023 | 156k | $1.8M |
| Parkman Healthcare Partners | Sep 2023 | 150k | $1.7M |
| First Manhattan | Sep 2023 | 135k | $1.6M |
| Boothbay Fund Management | Sep 2023 | 99k | $1.1M |
| Connective Capital Management | Dec 2023 | 58k | $829k |
| Geode Capital Management | Sep 2023 | 50k | $577k |
| Alliancebernstein | Sep 2023 | 47k | $544k |
| ALPS Advisors | Sep 2023 | 46k | $524k |
| Belvedere Trading | Sep 2023 | 35k | $403k |
| Hillhouse Capital Advisors | Sep 2023 | 32k | $365k |
| Morgan Stanley | Sep 2023 | 25k | $283k |
| Group One Trading | Sep 2023 | 2.2k | $25k |
| Tower Research Capital | Sep 2023 | 235.00 | $2.7k |